PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 20, 2011Journal of Clinical Oncology35 citations

From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia

View Full Paper
LWLoren D. Walensky

Key Points

Key points are not available for this paper at this time.

Abstract

Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2011.37.9339 Journal of Clinical Oncology - published online before print December 19, 2011 PMID: 22184389 From Mitochondrial Biology to Magic Bullet: Navitoclax Disarms BCL-2 in Chronic Lymphocytic Leukemia Loren D. WalenskyxLoren D. WalenskySearch for articles by this author Show More Dana-Farber Cancer Institute, Boston, MA https://doi.org/10.1200/JCO.2011.37.9339 First Page Full Text PDF Figures and Tables © 2011 by American Society of Clinical Oncology

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Loren D. Walensky (2011) studied this question.

synapsesocial.com/papers/69dd226f4006ebb8efe5313dhttps://doi.org/10.1200/jco.2011.37.9339
Ask AI
Helpful
Bookmark
Share
View Full Paper